Ilyang Pharmaceutical’s new ‘ER—GMP level’ factory for Supect
Ilyang Pharmaceutical(CEO Dong-yeon Kim) had a ceremony for completion of a manufacturing facility exclusively for “Supect,” a chronic myeloid leukemia, at the BioValley located in Jecheon-si, Chungcheongbuk-do, at 10am on Nov. 2.
The “Supect’ manufacturing facility, whose construction was start...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
